Transitioning between medical equipment suppliers does not affect ACL reconstruction outcomes in a high-volume setting.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 40652381.
- Also identified by DOI 10.1002/ksa.12775.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate whether changing medical equipment suppliers in anterior cruciate ligament reconstruction (ACLR) influences surgical time, revision rates and subjective outcomes. A retrospective cohort study was conducted using data from the Swedish Knee Ligament Registry (SKLR). On 1 September 2016, Capio Artro Clinic, Stockholm, Sweden, changed its supplier for all medical equipment, from Smith & Nephew (SN) to Arthrex (AR). Patients who underwent primary ACLR during the preceding year (from 1 September 2015) formed group SN and were compared with patients operated between 1 September 2016 and 1 September 2017, divided into three consecutive 4-month cohorts (AR1-3) for temporal comparison. Primary outcome was surgical time. Secondary outcomes were revision rates at 2 and 5 years, and the aggregate Knee injury and Osteoarthritis Outcome Score (KOOS<sub>4</sub>) at 2 years using thresholds for minimal important change (MIC), Patient Acceptable Symptom State (PASS), treatment failure (TF) and perioperative complications. A total of 1175 patients underwent a primary ACLR during the study period. Group SN included 521 patients, and Groups AR1-3, 654. Of the 521 patients in Group SN, 488 (93.7%) had surgical time recorded, with a median of 61 (interquartile range [IQR]: 50-73) min. In Groups AR1-3, 560 patients (85.6%) had surgical time recorded, with median times of 63 (IQR: 52-78), 60 (IQR: 50-70) and 60 (IQR: 50-70) min, respectively, showing no significant differences. Of the included patients, 573 (48.8%) completed KOOS at the 2-year follow-up, with no significant differences between groups regarding MIC, PASS or TF. Within 2 years, 31 patients (2.6%) underwent revision ACLR, and after 5 years, an additional 21 patients, totalling 52 (4.4%), with no significant group differences. Experienced ACL surgeons can transition between suppliers with acceptable outcomes, comparable surgical times and low complication rates. Level III.